NORWALK, Conn., Sept. 10, 2024 /PRNewswire/ — LifeSpan Vision Ventures today announced that it has closed an investment in Remedium Bio. The biotechnology company is developing a first-in-class adjustable-dose gene therapy platform called Prometheus™, which can replace a broad range of…